Programme 11 February

Graphics Norway Life Science 11 February.

09:30�C09:45 Welcome to Norway Life Science 2025

Svein St?len, Rector, University of Oslo
Eirik Lae Solberg, Governing Mayor of Oslo

Image may contain: Collar, Smile, Eyewear, Official, Throat. Eirik Lae Solberg.
^{Photo of Lae Solberg by Sturlason.}

09:45�C10:45 From Health Data Access to Value and Groundbreaking Research - Part 1

_{This session will be in Norwegian}

Stefan Woxstr?m, Senior Vice President Europe and Canada, AstraZeneca
Torgeir Micaelsen, State Secretary, Ministery of Digitalisation and Public Governance (Labour Party):
Digitalisering, KI og bruk av helsedata som drivkrefter for bedre helsetjenester, fremragende forskning og ny helsen?ring

Paneldiskusjon: Utvikling av morgendagens robuste helsevesen

Bj?rn Atle Bj?rnbeth, CEO, Oslo University Hospital
Guri R?rtveit, Director General, Norwegian Institute of Public Health (FHI)
Wenche P. Dehli, Municipal Director, City Council Department for Health and Care, Trondheim Municipality
Norwegian Directorate of Health (Helsedirektoratet), speaker TBA
Chairs: Camilla Stoltenberg, CEO, Norce & Per Morten Sandset, Vice-Rector, University of Oslo

Stefan Woxstr?m, AstraZeneca. Torgeir Micaelsen.
^{Photo of Micaelsen by Torbj?rn Tandberg.}

10:45�C11:10 Break

11:10�C12:00 From Health Data Access to Value and Groundbreaking Research - Part 2

_{This session will be in Norwegian}

Tone Varslot Stave, Head of health export, Innovation Norway:
Nullpunktsanalyse for eksportsatsing helse - overordnet presentasjon av Menons rapport med n?kkeltall for helseindustrien
Ole Andreassen, Professor, University of Oslo

Paneldiskusjon: N?dvendige tiltak for ? n? nasjonale ambisjoner

Erna Solberg, Leader, Conservative Party
Cathrine Thomassen, Director, GE Healthcare
Ingrid Teigland Akay, Managing Partner, Hadean Ventures
Kjetil Task��n, Head Institute for Cancer Research, Oslo University Hospital & Professor University of Oslo

Chair: Ishita Barua, Chief Health AI Officer, Livv Health

Tone Varslot Stave, Innovation Norway. Ole Andreassen, University of Oslo.

Erna Solberg, Conservative Party. Cathrine Thomassen, GE HealthCare. Ingrid Teigland Akay, Hadean Ventures. Kjetil Tasken. Ishita Barua
_{Foto Erna Solberg: Hans Kristian Thorbj?rnsen.}

12:00�C13:00 Lunch

13:00-14:00 Health data and AI: solutions for a better society

Timothy Miller, Vice President, Enterprise Science & Innovation, Thermo Fisher Scientific
Erwin B?ttinger, Chief Executive Officer, Wyss Center for Bio and Neuroengineering
Speaker TBA

Timothy M. Miller, Thermo Fisher Scientific. Erwin B?ttinger, Wyss Center.

14:00�C14:15 Break

14:15�C15:30 Parallel Sessions

AI and drug design - Precision tools for the largest global challenges

Scientists in the academic forefront will discuss how AI can be used for drug design to predict structure and effect.

Use and design of antimicrobial peptides as antimicrobials to fight antibiotic resistant pathogens �C possibilities and challenges
Morten Kjos, Associate Professor, The Norwegian University of Life Sciences
Title TBA
Cyril Franzen, R&D Operations Manager, ACD Pharma
AI-driven biological screening
Alexander Johannes Stasik, Research Scientist, SINTEF Digital
Cortex AI: Advancing Drug Discovery for Life Extension and Beyond
Ivan de Weber, CEO, Cortex Discovery

Chair: Timothy M Miller, Vice President, Enterprise Science & Innovation, Thermo Fisher Scientific

Event organizer: Norwegian University of Life Sciences, SINTEF and The Life Science Cluster

Using register data and RWE to improve population health - how can Norway excel?

Real-World Evidence on Pharmaceuticals for Regulatory Purpose in the EU �C Capitalizing on Norwegian health registry data in large European initiatives
Hedvig Nordeng, Professor, University of Oslo
Risk stratification with the ACG System using data from Norwegian health registries Jorid Kalseth, Senior Research Scientist, SINTEF
Title of presentation TBA
Richard Bergstrom, Vice President European Affairs, IQVIA
HPV vaccination �C how Norwegian and Nordic registry data can impact public health and support HPV-related cancer elimination globally
Stina Salomonsson, Outcome Research Executive Director, MSD

Chair: TBA

Event organizer: Oslo Cancer Cluster, SINTEF, LMI and The Life Science Cluster

Implementation of AI �C ethics, organization and trust

What happens when AI is implemented in practice?

Injecting knowledge in machine learning to increase trust in algorithms by health professionals and patients
Arnoldo Frigessi, Professor, University of Oslo and Director of the centre of excellence Integreat
What is right for ��this�� patient? Autonomy, trust and transparency in the era of medical AI Anna Smajdor, Professor, University of Oslo
Intelligent Resource Planning at Lovisenberg Diaconal Hospital - An Example of How AI Drives Value Creation in Norwegian Hospitals Olav Willumsen Haug?, CEO, Deep Insight
Making of Effective AI in Healthcare through Infrastructure and Process Reconfigurations
Alexander Kempton, Associate Professor, University of Oslo